These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22519486)

  • 21. [Clinical application of in vitro maturation of human immature oocytes for infertile women with polycystic ovary syndrome].
    Xu YP; Xiang HF; Zou WW; Li ZL; Zhang ZG; Zhou P; Cao YX
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):14-8. PubMed ID: 22455687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.
    Guo YH; Lu N; Zhang Y; Su YC; Wang Y; Zhang YL; Sun YP
    Contemp Clin Trials; 2012 Nov; 33(6):1206-10. PubMed ID: 22820320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment.
    Binder H; Dittrich R; Einhaust F; Krieg J; Müller A; Strauss R; Beckmann MW; Cupisti S
    Int J Fertil Womens Med; 2007; 52(2-3):69-81. PubMed ID: 18320864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management and obstetric outcome of ovarian hyperstimulation syndrome.
    Zareen N
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):86-90. PubMed ID: 18454892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful outcome of severe ovarian hyperstimulation syndrome (OHSS) with 27 liters of ascitic fluid removed by paracentesis.
    Grochowski D; Sola E; Kulikowski M; Kuczyński W; Wołczyński S; Szamatowicz M
    J Assist Reprod Genet; 1995 Jul; 12(6):394-6. PubMed ID: 8589562
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
    Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
    West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
    Spitzer D; Wogatzky J; Murtinger M; Zech MH; Haidbauer R; Zech NH
    Fertil Steril; 2011 Jun; 95(8):2742-4.e1. PubMed ID: 21411081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian salvage in bilaterally complicated severe ovarian hyperstimulation syndrome.
    Al Omari W; Ghazal-Aswad S; Sidky IH; Al Bassam MK
    Fertil Steril; 2011 Aug; 96(2):e77-9. PubMed ID: 21718996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
    Tarlatzis BC; Griesinger G; Leader A; Rombauts L; Ijzerman-Boon PC; Mannaerts BM
    Reprod Biomed Online; 2012 Apr; 24(4):410-9. PubMed ID: 22386594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
    Rogolino A; Coccia ME; Fedi S; Gori AM; Cellai AP; Scarselli GF; Prisco D; Abbate R
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):277-82. PubMed ID: 12695751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triggering final oocyte maturation with reduced doses of hCG in IVF/ICSI: a prospective, randomized and controlled study.
    Lin H; Wang W; Li Y; Chen X; Yang D; Zhang Q
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):143-7. PubMed ID: 21824709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Severe ovarian hyperstimulation syndrome treatment by decompressive paracentesis and self-transfusion of ascitis fluid].
    Kably Ambe A; Ruiz Anguas J; Sánchez de León A
    Ginecol Obstet Mex; 2006 Jun; 74(6):291-9. PubMed ID: 16970114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
    Owj M; Tehrani-Nejad ES; Amirchaghmaghi E; Baghestani AR; Ahmadi J
    Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ascitic fluid puncture in the treatment of severe forms of ovarian hyperstimulation syndrome].
    Machac S; Dostál J; Oborná I; Zahradnícková V; Brezinová J; Labanová M; Kudela M
    Ceska Gynekol; 2001 Sep; 66(5):333-6. PubMed ID: 11732230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Retrospective analysis of treatment for severe ovary hyperstimulation syndrome complicated by pleural effusion and ascites].
    Gong F; Guo H; Shen Y; Li J; Lu G; Lin G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 37(7):720-4. PubMed ID: 22886212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A severe case of ovarian hyperstimulation syndrome: 65 liters of ascites aspirated in an on-going IVF-ET twin pregnancy.
    Bar-Hava I; Orvieto R; Dicker D; Dekel A; Peley D; Ben-Rafael Z
    Gynecol Endocrinol; 1995 Dec; 9(4):295-8. PubMed ID: 8629457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy.
    Hatzipetros I; Gocze PM; Cziraky K; Kovacs K; Kalman E; Farkas B
    Reprod Biol Endocrinol; 2013 Sep; 11():91. PubMed ID: 24028152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.